Bird Rock Bio
is a California-based biopharmaceutical company that develops immuno-inflammatory regulators for healthcare applications... Read moreBird Rock Bio
is a California-based biopharmaceutical company that develops immuno-inflammatory regulators for healthcare applications... Read more
News
Aug 22, 2023
BioCentury
Bird Rock Bio: Why 5AM and Versant forged a deal to unite two cannabinoid companies
Aug 21, 2023
Endpoints News
Bird Rock Bio: Skye acquires Bird Rock Bio, weeks after Novo Nordisk says it will buy a CB1 developer
Aug 21, 2023
BioSpace
Bird Rock Bio: Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
Aug 21, 2023
MarketScreener
Bird Rock Bio: Skye Bioscience : Acquisition of Bird Rock Bio builds Skye's position as a leading endocannabinoid system-focused pharmaceutical company - Form 8-K
May 28, 2020
Pharmaceutical Business Review
Bird Rock Bio: Bird Rock Bio files IND application for phase 2 study of Nimacimab for treatment of renal diseases
Oct 17, 2019
PR Newswire
Press Release: Bird Rock Bio : Bird Rock Bio Announces Successful Completion of Phase 1B Safety Study and Readiness for Phase 2B Study of Nimacimab in Patients with Diabetic Kidney Disease
Jul 30, 2018
BioPortfolio
Bird Rock Bio: Bird Rock Bio Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13042018 Prices from USD $250
Mar 14, 2018
BioPortfolio
Bird Rock Bio: Bird Rock Bio Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 27022018 Prices from USD $250
Aug 14, 2017
BioPortfolio
Bird Rock Bio: Bird Rock Bio Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 25072017 Prices from USD $250
Jun 05, 2017
BioSpace
Bird Rock Bio: Bird Rock Bio Completes Single Ascending Dose Human Clinical Trial For Namacizumab; Generates Safety, Tolerability, And Pharmacokinetics Data; Prepares To Initiate Study In Non-Alcoholic Fatty Liver Disease Patients
Bird Rock Bio Competitors
1
2
3
4
5
6
7
8
9
10